YC W26
Ditto Biosciences
Evolutionary intelligence for autoimmune disease
About
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction
Founders
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Ditto Biosciences.
See family office activityIndustry & Focus
HealthcareDrug Discovery and Delivery